Living with IPF: Patient perspectives
Interstitial lung diseases (ILDs) include over 200 fibroinflammatory diseases that affect the alveolar interstitium of the lung1,2.
The most common of these is idiopathic pulmonary fibrosis (IPF) which accounts for between 17–37% of ILDs1.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
This content has been developed independently of the sponsors, Boehringer Ingelheim, who have had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.